Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Therapy Related Myeloid Neoplasms- Clinical, Pathologic and Genetic Characteristics - a Single Center Experience

Dina Sameh Soliman, MD MB, MMSc, Ahmed Al-Sabbagh, MD, Shehab Fareed Mohamed, MD, Susanna Jane Akiki, PhD, Halima El-Omri, MD, Firyal Ibrahim, MD, Mohamed A Yassin, MBBS, MSc, Prem Chandra, PhD

Blood (2019) 134 (Supplement_1): 5169.

https://doi.org/10.1182/blood-2019-124951

Published: 2019

Journal Articles

Histiocytic Necrotizing Lymphadenitis, a Benign Mimic of Lymphoma Presenting with B Symptoms

Varsha Gupta, MD, Shreya Gor, MD, Anmol S Cheema, MD, Ravneet Bajwa, MD, Carrie Edelman, MD, Ethan Jeffrey Wasserman, MD

Blood (2018) 132 (Supplement 1): 4949.

https://doi.org/10.1182/blood-2018-99-118826

Published: 2018

Journal Articles

Autoimmune-Associated Human Leukocyte Antigen (HLA) Alleles As Risk Factors for Heparin-Induced Thrombocytopenia (HIT) Antibodies

Ray Zhang, MD PhD, Brian Duffy, MA, Vinzenz Lange, PhD, Charles S. Eby, MD, Chang Liu, MD PhD

Blood (2018) 132 (Supplement 1): 3737.

https://doi.org/10.1182/blood-2018-99-120074

Published: 2018

Journal Articles

Tumor Necrosis Factor-Alpha Inhibitor Medications for Inflammatory Conditions and Incidence of Multiple Myeloma

Gregory S. Calip, PharmD, MPH, PhD, Wan-Ju Lee, MS, Todd A. Lee, PharmD, PhD, Glen T. Schumock, PharmD, MBA, PhD, Brian C.-H. Chiu, PhD

Blood (2015) 126 (23): 2954.

https://doi.org/10.1182/blood.V126.23.2954.2954

Published: 2015

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Severe Auto-Immune Disease Adult Patients: Analysis of Outcomes from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGMT-TC) in Light of the European Society for Blood and Marrow Transplantation (EBMT) Activity

Perrine Guillaume-Jugnot, MD, Zora Marjanovic, Myriam Labopin, MD, Louis Terriou, MD, Christophe Deligny, Bruno Lioure, MD, Thierry Martin, Veronique Leblond, MD PhD, Gregory Pugnet, Didier Blaise, Régis Peffault de Latour, MD, Ibrahim Yakoub-Agha, MD PhD, John A Snowden, MD FRCP, FRCPath, Dominique Farge, PhD MD

Blood (2015) 126 (23): 1985.

https://doi.org/10.1182/blood.V126.23.1985.1985

Published: 2015

Journal Articles

Risk of Non-Hodgkin Lymphoma Following Treatment of Inflammatory Conditions with Tumor Necrosis Factor-Alpha Inhibitors

Gregory S. Calip, PharmD, MPH, PhD, Wan-Ju Lee, MS, Todd A. Lee, PharmD, PhD, Glen T. Schumock, PharmD, MBA, PhD, Brian C.-H. Chiu, PhD

Blood (2015) 126 (23): 2653.

https://doi.org/10.1182/blood.V126.23.2653.2653

Published: 2015

Journal Articles

Long-Term Survival In Patients With Acute Steroid Refractory Graft-Versus-Host-Disease (SR-GVHD) Treated With Infliximab Combined With Daclizumab

Sanaz Nicky Soltani, MD, Ramaprasad Srinivasan, MD, PhD, Theresa Jerussi, PAc, A. John Barrett, Thomas E Hughes, PharmD, BCOP, Catalina Ramos, RN, BSN, Lisa Cook, RN, BSN, Elena Cho, RN, MSN, Richard W. Childs, MD

Blood (2013) 122 (21): 4624.

https://doi.org/10.1182/blood.V122.21.4624.4624

Published: 2013

Journal Articles

Poor Response To Imatinib In Patients With Secondary Chronic Myelogenous Leukemia

Jonathan Thompson, MD,, Kendra L. Sweet, MD, Ling Zhang, MD, Jasleen K Randhawa, MD, Christopher R. Chitambar, MD, Jessica K Altman, MD, Javier Pinilla, MD, PhD, Ehab Atallah, MD

Blood (2013) 122 (21): 5170.

https://doi.org/10.1182/blood.V122.21.5170.5170

Published: 2013

Journal Articles

Presence Of CD55- and/Or CD59-Deficient Erythrocytes In Patients With Rheumatic Diseases: An Immune-Mediated Phenomenon?

John V. Asimakopoulos, Evangelos Terpos, Loula Papageorgiou, Olga Kampouropoulou, Dimitrios Christoulas, Anastasios Giakoumis, George Vaiopoulos, Kostas Konstantopoulos, Maria K. Angelopoulou, Theodoros P. Vassilakopoulos, John Meletis

Blood (2013) 122 (21): 3429.

https://doi.org/10.1182/blood.V122.21.3429.3429

Published: 2013

Journal Articles

Acquired Erythrocytosis on Treatment with Infliximab for Ankylosing Spondylitis

Manoj Bupathi, MD, Maria Antonelli, MD, Paul Hergenroeder, MD, Muhammad Khan, MD

Blood (2010) 116 (21): 5142.

https://doi.org/10.1182/blood.V116.21.5142.5142

Published: 2010

Journal Articles

Improving the Sensitivity and the Specificity of HLA-B27 Typing by Replacing Serological Tests with a TaqMan-PCR Assay

Xiaoduan Weng, MD, PhD, Louise Robin, TM, Marie-lise Audet, BSc, Linda Hébert, TM, Ginette Lapointe, TM, Micheline Major, TM, Bernard Lemieux, MD, FRCPC, Guy Biron, MD, FRCPC, Karl Bélanger, MD, FRCPC, Denis Soulières, MD, FRCPC, MSc

Blood (2008) 112 (11): 4720.

https://doi.org/10.1182/blood.V112.11.4720.4720

Published: 2008

Journal Articles

Tumor Necrosis Factor Alpha (TNF-a) Blockade and Risk of Lymphoma: Systematic Review and Analysis of Literature

Jeyanthi Ramanarayanan, Shalu Pahuja, Myron S Czuczman, Francisco J. Hernandez-Ilizaliturri, MD

Blood (2008) 112 (11): 5278.

https://doi.org/10.1182/blood.V112.11.5278.5278

Published: 2008

Journal Articles

Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders

Linda Morris Brown, Gloria Gridley, David Check, Ola Landgren

Blood (2008) 111 (7): 3388–3394.

https://doi.org/10.1182/blood-2007-10-121285

Published: 2008

Includes: Supplemental data

Journal Articles

Myelodysplasia Following Therapy with Tumour Necrosis Factor-alpha (TNF α) Inhibitors - An Uncommon Occurence.

Anil V. Kamat, MBBS, MRCP, Raphael Ezekwesili, MBBS,FRCP,FRCPath, Yasser El-Miedany, MBBCh,MRCP

Blood (2006) 108 (11): 4844.

https://doi.org/10.1182/blood.V108.11.4844.4844

Published: 2006

NARROW

Therapy Related Myeloid Neoplasms- Clinical, Pathologic and Genetic Characteristics - a Single Center Experience

Histiocytic Necrotizing Lymphadenitis, a Benign Mimic of Lymphoma Presenting with B Symptoms

Autoimmune-Associated Human Leukocyte Antigen (HLA) Alleles As Risk Factors for Heparin-Induced Thrombocytopenia (HIT) Antibodies

Tumor Necrosis Factor-Alpha Inhibitor Medications for Inflammatory Conditions and Incidence of Multiple Myeloma

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Severe Auto-Immune Disease Adult Patients: Analysis of Outcomes from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGMT-TC) in Light of the European Society for Blood and Marrow Transplantation (EBMT) Activity

Risk of Non-Hodgkin Lymphoma Following Treatment of Inflammatory Conditions with Tumor Necrosis Factor-Alpha Inhibitors

Long-Term Survival In Patients With Acute Steroid Refractory Graft-Versus-Host-Disease (SR-GVHD) Treated With Infliximab Combined With Daclizumab

Poor Response To Imatinib In Patients With Secondary Chronic Myelogenous Leukemia

Presence Of CD55- and/Or CD59-Deficient Erythrocytes In Patients With Rheumatic Diseases: An Immune-Mediated Phenomenon?

Acquired Erythrocytosis on Treatment with Infliximab for Ankylosing Spondylitis

Improving the Sensitivity and the Specificity of HLA-B27 Typing by Replacing Serological Tests with a TaqMan-PCR Assay

Tumor Necrosis Factor Alpha (TNF-a) Blockade and Risk of Lymphoma: Systematic Review and Analysis of Literature

Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders

Myelodysplasia Following Therapy with Tumour Necrosis Factor-alpha (TNF α) Inhibitors - An Uncommon Occurence.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only